Futura Medical plc (FUM.L) Research

Futura Medical plc operates as a pharmaceutical firm specializing in the creation and advancement of consumer healthcare products. The company primarily targets the sexual health and pain management sectors. Its leading innovation is MED3000, a topical gel specifically formulated to treat erectile dysfunction. Additionally, Futura Medical offers a variety of pain relief solutions, including TPR100, a topical diclofenac gel; CBD100, a cannabidiol-based topical application; and TIB200, an ibuprofen topical gel. Established in 2001, the company is headquartered in Guildford, United Kingdom.

Market snapshot

Symbol
FUM.L
Price
$0.54
Day change
+0.37%
Market cap
$1.8M
P/E ratio
-0.21x
52-week range
0.5-15
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 3 months

Peer companies

  • ANGLE plc (AGL.L)
  • Cizzle Biotechnology Holdings Plc (CIZ.L)
  • Genflow Biosciences plc (GENF.L)
  • GENinCode plc (GENI.L)
  • Nuformix plc (NFX.L)
  • Oxford BioDynamics Plc (OBD.L)
  • OptiBiotix Health Plc (OPTI.L)
  • RUA Life Sciences plc (RUA.L)

Open Futura Medical plc (FUM.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.